Medindia
Medindia LOGIN REGISTER
Advertisement

Roxane Laboratories, Inc. Announces the Launch of Calcium Acetate Capsules, 667mg

Thursday, October 16, 2008 General News
Advertisement
COLUMBUS, Ohio, Oct. 15 Roxane Laboratories, Inc.announced today the approval of its Abbreviated New Drug Application (ANDA)for Calcium Acetate Capsules, 667mg by the U.S. Food and Drug Administration.The product is available in bottles of 200 capsules for immediate shipment towholesalers and pharmacies nationwide.
Advertisement

(Logo: http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO )

Roxane Laboratories' Calcium Acetate Capsules, 667mg are AB rated toPhosLo(R) (calcium acetate) capsules. Annual sales of Calcium AcetateCapsules, 667mg are approximately $84.8 Million(1).
Advertisement

Full prescribing information for Calcium Acetate Capsules, 667mg isavailable on the Roxane Laboratories website at www.Roxane.com or upon requestby calling Roxane Laboratories Technical Product Information at1.800.962.8364.

About Roxane Laboratories, Inc.

Roxane Laboratories is located in Columbus, OH in a modern 500,000 squarefoot manufacturing and laboratory facility. The facility spans 70 acres andcurrently employs over 1,000 people. Currently, Roxane Laboratories marketsover 75 medications in nearly 250 package sizes, focusing on an expanding lineof Multisource pharmaceutical products including: bulk and unit-dose liquidsand solids; coated, sustained-release and controlled-release tablets; nasalsprays, cytotoxics and CII narcotics.

Roxane Laboratories, Inc., is a subsidiary of Boehringer IngelheimCorporation, based in Ridgefield, CT and a member of the Boehringer Ingelheimgroup of companies.

About Boehringer Ingelheim

Boehringer Ingelheim Corporation based in Ridgefield, CT, is the USheadquarters to seven subsidiaries and a member of the Boehringer Ingelheimgroup of companies.

The Boehringer Ingelheim group is one of the world's 20 leadingpharmaceutical companies. Headquartered in Ingelheim, Germany, it operatesglobally with 135 affiliates in 47 countries and approximately 39,800employees. Since it was founded in 1885, the family-owned company has beencommitted to researching, developing, manufacturing and marketing novelproducts of high therapeutic value for human and veterinary medicine.

In 2007, Boehringer Ingelheim posted net sales of US $15.0 billion (10.9billion euro) while spending approximately one-fifth of net sales in itslargest business segment, Prescription Medicines, on research and development.

For more information on Boehringer Ingelheim, please visithttp://us.boehringer-ingelheim.com .

(1) IMS MAT dollar sales ending 6/2008

PhosLo(R) is a registered trademark of Fresenius Medical Care.

SOURCE Roxane Laboratories, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close